Medicaid Pharmacy and Therapeutics Committee

Given statutory changes as a result of the 2013 – 2014 Executive Budget the Pharmacy & Therapeutics (P&T) Committee has been dissolved effective April 1, 2013. The responsibilities of the former P&T Committee, including those related to the Preferred Drug Program (PDP) and Clinical Drug Review Program (CDRP) have been transitioned to the Drug Utilization Review (DUR) Board. Information regarding the DUR Program and the DUR Board, including DUR Board meetings, can be accessed at:

Meeting Agendas

Meeting Summaries